EKF Diagnostics (LON:EKF – Get Free Report) posted its earnings results on Tuesday. The company reported GBX 1.38 ($0.02) earnings per share for the quarter, Digital Look Earnings reports. EKF Diagnostics had a net margin of 9.37% and a return on equity of 7.03%.
EKF Diagnostics Trading Up 7.3 %
Shares of EKF opened at GBX 22 ($0.28) on Tuesday. EKF Diagnostics has a twelve month low of GBX 18.40 ($0.24) and a twelve month high of GBX 33.80 ($0.44). The stock has a market cap of £97.78 million, a PE ratio of 20.47 and a beta of 0.57. The company has a quick ratio of 1.77, a current ratio of 4.60 and a debt-to-equity ratio of 0.34. The business’s 50-day moving average price is GBX 23.35 and its 200-day moving average price is GBX 25.91.
EKF Diagnostics Company Profile
● Point-of-Care analysers in the key areas of Hematology and Diabetes
● Life Sciences services provide specialist manufacture of enzymes and custom products for use in diagnostic, food and industrial applications.
EKF has headquarters in Penarth (near Cardiff) and operates five manufacturing sites across the US and Germany, selling into over 120 countries world-wide.
See Also
- Five stocks we like better than EKF Diagnostics
- Manufacturing Stocks Investing
- Pharma Frenzy: Volatility Ignites Biotech Sector
- Bank Stocks – Best Bank Stocks to Invest In
- Warren Buffett Thinks This Country Could Be the Next Big Bet
- Where Do I Find 52-Week Highs and Lows?
- Not in a Rush to Buy Gold? 5 Stocks to Buy on the Dip
Receive News & Ratings for EKF Diagnostics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for EKF Diagnostics and related companies with MarketBeat.com's FREE daily email newsletter.
